Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells.
about
HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cellsSublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation.Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.Entinostat for the treatment of breast cancer.Histone Deacetylase Inhibitors as Anticancer Drugs.Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacySynergistic immunologic targets for the treatment of prostate cancer.Human endogenous retroviruses and cancer.Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.Stochastics of Cellular Differentiation Explained by Epigenetics: The Case of T-Cell Differentiation and Functional Plasticity.Modulation of antitumor immunity with histone deacetylase inhibitors.Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi.Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types
P2860
Q37607905-A94FB4AE-F9FB-4C9B-9D02-B924F34E96AAQ37686296-57ABDD87-BF0D-46C1-A158-4B3F7DC9667FQ38600417-1FCCCDBF-A42E-4E7E-85EA-DCDF42606813Q38674317-E679433B-9EF4-49D3-926A-DF52DF900D02Q38696932-26B2CB6C-D0D4-4576-97FD-5D96F23BD840Q38749824-FF38768F-53B4-4A77-95D1-83188D46AECFQ38904873-EA3D4376-81C3-4A4B-AA98-F68800E698DBQ38982814-C33F5DAC-1BE2-44B6-9483-2DDC6933F956Q39093352-02BAF934-9C3A-4615-BA61-9D19A2C0C59DQ39381251-802F8DB5-6AE3-4703-A550-848B26B0494BQ47965246-5CDD5751-8DCA-4639-A5E7-B9B1B6831677Q49557954-554AB8DF-6C8C-4C96-876D-61A4C7F4CB8AQ52590685-97B15D46-7884-44F2-B0D3-9325EF00074FQ58130496-2713247A-55A2-4B2D-A981-682349AF3B37
P2860
Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibitors of histone deacetyl ...... te and breast carcinoma cells.
@en
type
label
Inhibitors of histone deacetyl ...... te and breast carcinoma cells.
@en
prefLabel
Inhibitors of histone deacetyl ...... te and breast carcinoma cells.
@en
P2093
P2860
P356
P1433
P1476
Inhibitors of histone deacetyl ...... ate and breast carcinoma cells
@en
P2093
Anthony S Malamas
James W Hodge
Kwong Y Tsang
Soldano Ferrone
P2860
P304
P356
10.18632/ONCOTARGET.7180
P407
P577
2016-02-01T00:00:00Z